A novel vascular smooth muscle chymase is upregulated in hypertensive rats

Journal of Clinical Investigation

Volumn 107, Issue 6, 2001, Pages 703-715

  Guo, Caiying ^b   Ju, Haisong ^b   Leung, Debbie ^b   Massaeli, Hamid ^b   Shi, Mingda ^b   Rabinovitch, Marlene ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; CAPTOPRIL; CHYMASE; CHYMOSTATIN; COMPLEMENTARY DNA; DIPEPTIDYL CARBOXYPEPTIDASE; EDETIC ACID;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERTENSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY ARTERY; RAT; SEQUENCE HOMOLOGY; SOUTHERN BLOTTING; VASCULAR SMOOTH MUSCLE;

EID: 0035107611     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI9997     Document Type: Article

References (72)

1. Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension
2. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension
3. Is there an internal cardiac renin-angiotensin system?
4. Vascular hypertrophy in hypertension: Role of the renin-angiotensin system
5. Do ACE inhibitors modulate atherosclerosis?
6. Renin-angiotensin system and myocardial collagen matrix: Modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism
7. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells
8. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall
9. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: Effects of angiotensin receptor antagonism and converting enzyme inhibition
10. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial
11. Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat
12. Trandolapril inhibits atherosclerosis in the Watanabe heritable hyperlipidemic rabbit
13. Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol diet
14. Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall
15. Direct formation of angiotensin II without renin or converting enzyme in the ischemic dog heart
16. Angiotensin II-forming pathways in normal and failing human hearts
17. Activation of angiotensin II-forming chymase in the cardiomyopathic hamster heart
18. Effects of angiotensin II generated by an angiotensin converting enzyme-independent pathway on left ventricular performance in the conscious baboon
19. Cloning of the gene and cDNA for human heart chymase
20. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart
21. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart
22. Widespread tissue distribution of human chymase
23. Marked species-difference in the vascular angiotensin II-forming pathways: Humans versus rodents
24. Activation of two angiotensin-generating systems in the balloon-injured artery
25. Vasoconstrictor action of angiotensin I-convertase and the synthetic substrate (Pro11,D-Alal2)-angiotensin I
26. Conversion of angiotensin I to angiotensin II in dog isolated renal artery: Role of two different angiotensin II-generating enzymes
27. Characterization of chymase from human vascular tissues
28. Structure, chromosomal assignment, and deduced amino acid sequence of a human gene for mast cell chymase
29. Induction of chymase that forms angiotensin II in the monkey arherosclerotic aorta
30. Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries
31. Local angiotensin II generation in the rat heart: Role of renin uptake
32. Angiotensin II formation from ACE and chymase in human and animal hearts: Methods and species considerations
33. Role of endothelium in angiotensin II formation by the rat aorta and arterial bed
34. Contractile effects of tetradecapeptide renin substrate on rat femoral resistance vessels
35. Substrare-dependent angiotensin II formation in the peripheral circulation
36. Aortic smooth muscle cells are able to convert angiotensin I to angiotensin II
37. Angiotensin II forming activity of vascular endothelial and smooth muscle cells
38. Rapid production of full-length cDNAs from tare transcripts: Amplification using a single gene-specific oligonucleotide primer
39. An efficient salt-chloroform extraction of DNA from blood and tissues
40. An analysis of 5_ -noncoding sequences from 699 vertebrate messenger RNAs
41. Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease
42. The structure of an antigenic determinant in a protein
43. Dipeptide processing activates recombinant human prochymase
44. Chymotrypsin- and trypsin-type serine proteases in rat mast cells: Properties and functions
45. Cloning of the mast cell protease, RMCP II. Evidence for cell-specific expression and a multi-gene family
46. Myelomonocytic cell lineage expression of the neutrophil elastase gene
47. Role of mast cells in atherosclerosis
48. Role of mast cell chymase in the extracellular processing of big-endothelial to endothelin-1 in the perfused rat lung
49. Inactivation of bradykinin and kallidin by cathepsin G and mast cell chymase
50. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase
51. Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase
52. Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain
53. Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G
54. Structural studies on human type IV collagen
55. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases
56. Distinct multisite synergistic interaction s determine substrate specificities of human chymase and rat chymase-I for angiotensin II formation and degradation
57. Angiotensin II-forming activity in a reconstructed ancestral chymase
58. Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I
59. Processing of procarboxypeptidase A and other zymogens in murine mast cells
60. Human prochymase activation. A novel role for heparin in zymogen processing
61. Effect of delaptil on the vascular angiotensin II release in isolated hind legs of the spontaneously hypertensive rat: Evidence for potential relevance of vascular angiotensin II to the maintenance of hypertension
62. Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats
63. The effect of analogues of chymostatin on lysosomal and non-lysosomal components of protein degradation in isolated hepatocytes
64. Protease inhibitors reduce lysosomal acid phospholipase A1 activity in cultured rat hepatocytes
65. Protease inhibitor suppression of colon and anal gland carcinogenesis induced by dimethylhydrazine
66. Proteases occurring in the cell membrane: A possible cell receptor for the Bowman-Birk type of protease inhibitors
67. Angiotensin II and the heart: On the intracrine renin-angiotensin system
68. Angiotensin II-binding protein in adult and neonatal rat heart
69. Immunohistochemical localization of angiotensin II receptors (AT1) in the heart with and-peptide antibodies showing a positive chronotropic effect
70. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro
71. Spontaneously hypertensive rats develop pulmonary hypertension and hypertrophy of pulmonary venous sphincters
72. Secretory granule proteases in rat mast cells. Cloning of 10 different serine proteases and a carboxypeptidase A from various rat mast cell populations